Marc R. Schneebaum is CFO at SYNTA PHARMACEUTICALS CORP (MDGL). They have made 2 open-market trades across 2 companies since 2008, most recently 2018-06-11.
CIK 0001396871
1 open-market purchase totalling $10K since 2008, against 1 sale. Too few scored purchases to measure a record yet.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.